Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Kim

Showing results (21-30 of 269) with videos related to

Pageof 27
Sort By:
Gastroenterology|November 2, 2013
An ALTer ego of serum ALT: is it more than a marker of liver inflammation?Donghee Kim, W Ray Kim
Hepatology (Baltimore, Md.)|March 6, 2013
In the eye of the B-holder: natural history of chronic hepatitis BSurakit Pungpapong, W Ray Kim
Hepatology (Baltimore, Md.)|January 24, 2015
A glass half full: Implications of screening for hepatitis C virus in the era of highly effective antiviral therapyGlen Lutchman, W Ray Kim
The American Journal of Gastroenterology|May 21, 2009
Hyponatremia in hepatic encephalopathy: an accomplice or innocent bystander?Byung Cheol Yun, W Ray Kim
Gastroenterology|February 24, 2010
Predicting response to pegylated interferon/ribavirin-based therapy in genotype 1 chronic hepatitis C patients: results of 3 independent genome-wide association studiesSumeet K Asrani, W Ray Kim
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 7, 2003
Is the change in MELD score a better indicator of mortality than baseline MELD score?Patrick S Kamath, W Ray Kim
Hepatology (Baltimore, Md.)|August 30, 2008
Benefits of "the benefit model" in liver transplantationW Ray Kim, Walter K Kremers
Clinics in Liver Disease|November 6, 2008
The global impact of hepatic fibrosis and end-stage liver diseaseYoung-Suk Lim, W Ray Kim
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Recurrent hepatocellular carcinoma: it's the virus!W Ray Kim, Gregory J Gores
Health Economics|August 31, 2002
Bayesian estimation, simulation and uncertainty analysis: the cost-effectiveness of ganciclovir prophylaxis in liver transplantationDavid J Vanness, W Ray Kim
Pageof 27

Showing results (21-30 of 269) with videos related to

Sort By:
Pageof 27
Gastroenterology|November 2, 2013
An ALTer ego of serum ALT: is it more than a marker of liver inflammation?Donghee Kim, W Ray Kim
Hepatology (Baltimore, Md.)|March 6, 2013
In the eye of the B-holder: natural history of chronic hepatitis BSurakit Pungpapong, W Ray Kim
Hepatology (Baltimore, Md.)|January 24, 2015
A glass half full: Implications of screening for hepatitis C virus in the era of highly effective antiviral therapyGlen Lutchman, W Ray Kim
The American Journal of Gastroenterology|May 21, 2009
Hyponatremia in hepatic encephalopathy: an accomplice or innocent bystander?Byung Cheol Yun, W Ray Kim
Gastroenterology|February 24, 2010
Predicting response to pegylated interferon/ribavirin-based therapy in genotype 1 chronic hepatitis C patients: results of 3 independent genome-wide association studiesSumeet K Asrani, W Ray Kim
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 7, 2003
Is the change in MELD score a better indicator of mortality than baseline MELD score?Patrick S Kamath, W Ray Kim
Hepatology (Baltimore, Md.)|August 30, 2008
Benefits of "the benefit model" in liver transplantationW Ray Kim, Walter K Kremers
Clinics in Liver Disease|November 6, 2008
The global impact of hepatic fibrosis and end-stage liver diseaseYoung-Suk Lim, W Ray Kim
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Recurrent hepatocellular carcinoma: it's the virus!W Ray Kim, Gregory J Gores
Health Economics|August 31, 2002
Bayesian estimation, simulation and uncertainty analysis: the cost-effectiveness of ganciclovir prophylaxis in liver transplantationDavid J Vanness, W Ray Kim
Pageof 27